Table 5.
Serum |
Tibia |
|||||||
---|---|---|---|---|---|---|---|---|
Treatment | ALP | Ca | P | CT | TBS | Ca | Mg | P |
A | 230 ± 33b | 4.31 ± 0.14b | 1.86 ± 0.28 | 35.96 ± 2.21b | 478 ± 45b | 20.0 ± 1.2c | 2.67 ± 0.33 | 84.9 ± 5.8b |
B | 250 ± 37b | 4.75 ± 0.23a | 1.88 ± 0.30 | 35.90 ± 2.01b | 533 ± 58ab | 28.8 ± 1.0b | 2.43 ± 0.55 | 82.6 ± 8.8b |
C | 352 ± 79a | 4.79 ± 0.35a | 2.20 ± 0.28 | 83.79 ± 7.67a | 676 ± 94a | 31.9 ± 2.7a | 2.56 ± 0.36 | 100.5 ± 19.0a |
P-value | 0.041 | 0.009 | 0.082 | 0.005 | 0.001 | <0.001 | 0.678 | 0.053 |
Data are presented as mean value ± SD. Mean values without the same mark (a, b) represent statistically significant differences (P < 0.05). Alkaline phosphatase (ALP, U/L), calcitonin (CT, pg/mL), calcium in serum (Ca, mg/dL), phosphorus in the serum (P, mg/dL), tibia breaking strength (TBS, kg/cm2), calcium in tibia (Ca, %ash), magnesium (Mg, % ash), phosphorus in the bone (P, % ash).